RRAD and lung carcinoma: RRAD mRNA levels were significantly reduced (by ~4-fold) in a high percentage of lung cancer samples we analyzed (17/24) compared with their matched adjacent normal lung tissues (p=1.089E-11; Figure 2A, B), which is consistent with previous reports [20, 21].